Skip to main content
Erschienen in: Journal of Translational Medicine 1/2010

Open Access 01.11.2010 | Poster presentation

Increased expression of A-kinase anchoring proteins in T cells from systemic lupus erythematosus patients

verfasst von: M J Pérez-Lorenzo, M Galindo, A J García-González, G Criado

Erschienen in: Journal of Translational Medicine | Sonderheft 1/2010

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Introduction

Deficient activation of protein kinase A (PKA) is a characteristic of T cells in systemic lupus erythematosus (SLE). A-kinase Anchoring Proteins (AKAPs) associate to and regulate the activity of PKA [1]. Furthermore, some AKAPs are expressed in T cells and influence their function [2]. Therefore, altered expression and/or function of AKAPs can play a role in the deregulated activity of PKA observed in SLE T cells.

Aims

To analyse the expression of different AKAPs in T cells isolated from SLE patients.

Patients and methods

T cells were isolated by negative selection using magnetic beads from SLE patients (n= 12) and healthy controls (HC, n= 12). RNA was purified and levels of AKAP79, AKAP95 and AKAP450 mRNA were quantified by RT-qPCR. Subsequently, the analysis of AKAP79 expression was extended to include a total of 24 SLE patients and19 HC. In addition, AKAP79 protein was detected by Western Blot and quantified with Quantity One software.

Results

Levels of AKAP450 mRNA were comparable in HC and SLE T cells (10.73 +/- 0.73 (HC, n= 12) vs 12.69 +/- 1.09 (SLE, n= 12), P= 0.15). However, T Cells from SLE patients had significantly higher levels of AKAP79 and AKAP95 mRNA than HC (AKAP79: 1.99 +/- 0.29 (HC, n= 19) vs 3.61 +/- 0.72 (SLE, n= 24), P= 0.04; AKAP95: 2.58 +/- 0.18 (HC, n= 12) vs 4.13 +/- 0.31 (SLE, n= 12), P= 0.0005). Analysis of AKAP79 protein levels showed increased levels of AKAP79 in SLE T cells compared to HC T cells (0.38 ± 0.05 (HC) vs 0.75 ± 0.18 (SLE), P= 0.06).

Conclusions

Increased levels of AKAP79 and AKAP95 in T cells from SLE patients can contribute to the deregulation of PKA activity in these cells.
Open AccessThis article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Literatur
1.
Zurück zum Zitat Jarnaess E, Taskén K: Spatiotemporal control of cAMP signalling processes by anchored signalling complexes. Biochem Soc Trans. 2007, 35: 931-7. 10.1042/BST0350931.CrossRefPubMed Jarnaess E, Taskén K: Spatiotemporal control of cAMP signalling processes by anchored signalling complexes. Biochem Soc Trans. 2007, 35: 931-7. 10.1042/BST0350931.CrossRefPubMed
2.
Zurück zum Zitat Schillace RV, Carr SD: The role of Protein Kinase A and A Kinase Anchoring proteins in modulating T cell activation: Progress and future directions. Crit Rev Immunol. 2006, 26: 113-31.CrossRefPubMed Schillace RV, Carr SD: The role of Protein Kinase A and A Kinase Anchoring proteins in modulating T cell activation: Progress and future directions. Crit Rev Immunol. 2006, 26: 113-31.CrossRefPubMed
Metadaten
Titel
Increased expression of A-kinase anchoring proteins in T cells from systemic lupus erythematosus patients
verfasst von
M J Pérez-Lorenzo
M Galindo
A J García-González
G Criado
Publikationsdatum
01.11.2010
Verlag
BioMed Central
Erschienen in
Journal of Translational Medicine / Ausgabe Sonderheft 1/2010
Elektronische ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-8-S1-P49

Weitere Artikel der Sonderheft 1/2010

Journal of Translational Medicine 1/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.